CAS 474960-44-6

2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxybenzenesulfonamide

CAS: 474960-44-6

Formula: C₁₉H₂₂BrClN₂O₅S

Purezza: 99%

Colore e forma: Solid

Peso molecolare: 505.8104

Ref: IN-DA00DGSZ

SB 657510

CAS: 474960-44-6

Formula: C₁₉H₂₂BrClN₂O₅S

Peso molecolare: 505.81

Ref: 7W-GL4859

SB-657510

CAS: 474960-44-6

SB-657510

Formula: C₁₉H₂₂BrClN₂O₅S

Purezza: ≥98%

Peso molecolare: 505.81

Ref: 54-BUP08857

SB-657510

CAS: 474960-44-6

(R)-2-Bromo-N-(4-chloro-3-((1-methylpyrrolidin-3-yl)oxy)phenyl)-4,5-dimethoxybenzenesulfonamide

Formula: C₁₉H₂₂BrClN₂O₅S

Purezza: 99%

Peso molecolare: 505.81

Ref: IN-DG01178920

SB 657510

Prodotto controllato

CAS: 474960-44-6

Formula: C₁₉H₂₂BrClN₂O₅S

Colore e forma: Neat

Peso molecolare: 505.81

Ref: TR-S155043

SB 657510

CAS: 474960-44-6

SB 657510 is a pharmaceutical compound, classified as a small-molecule antiviral agent, which is derived through synthetic organic chemistry. It operates by targeting specific viral replication mechanisms, inhibiting the function of key viral enzymes necessary for the proliferation of viral particles. This mode of action disrupts the lifecycle of the virus and impairs its ability to spread within the host organism.

Formula: C₁₉H₂₂BrClN₂O₅S

Purezza: Min. 95%

Peso molecolare: 505.81 g/mol

Ref: 3D-ZTA96044

SB-657510

CAS: 474960-44-6

SB-657510: UT antagonist, Ki (nM) - human 61, monkey 17, cat 30, rat 65, mouse 56; reduces UII-induced inflammation, aids diabetic atherosclerosis.

Formula: C₁₉H₂₂BrClN₂O₅S

Purezza: 98.06%

Colore e forma: Solid

Peso molecolare: 505.81

Ref: TM-T12848